crime

Spurious ointment racket busted; Delhi Police recovers material worth Rs 2 crore from Ghaziabad unit

Published by
PTI

The Delhi Police has busted a major interstate racket allegedly involved in the manufacture, repackaging and nationwide sale of spurious Schedule-H medicines, an official said on Sunday.

Police have also located a manufacturing unit and seized counterfeit drugs and raw material worth over Rs 2.3 crore.

According to the police, two men — Gaurav Bhagat, a resident of Uttar Pradesh’s Ghaziabad, and Shree Ram alias Vishal Gupta of northeast Delhi’s Sabhapur — have been arrested in the case, he said.

“The operation was carried out by the Crime Branch. The accused were engaged in producing and selling counterfeit versions of popular prescription ointments, including Betnovate-C and Clop-G, which are widely used for treating skin infections, allergies and sports-related injuries,” Deputy Commissioner of Police (Crime Branch) Aditya Gautam said in a statement.

The officer further said the spurious medicines were sold as genuine branded products, posing a serious risk to public health.

Acting on inputs, the Crime Branch team first conducted a raid at Teliwara in Sadar Bazar, one of the country’s largest wholesale pharmaceutical and cosmetic markets.

“During the raid, a large quantity of counterfeit Schedule-H ointments was recovered. Subsequent technical analysis and follow-up intelligence led the team to a manufacturing unit operating from Meerpur Hindu village in the Loni area of Ghaziabad.

“A search of the premises resulted in the recovery of counterfeit medicines, huge quantities of raw chemicals, packing material, empty tubes bearing forged brand labels and machinery used for mixing, filling and sealing ointments,” the DCP said.

He further said drug inspectors from the North and Central Zones of Delhi and Uttar Pradesh, along with authorised representatives of the concerned pharmaceutical companies, conducted spot inspections and drew samples from the seized stock. They confirmed that the medicines were counterfeit and neither manufactured nor supplied by their companies.

The accused were also found to be operating without any valid licence to manufacture, store or sell pharmaceutical products, he added.

Police said that an FIR was registered at the Crime Branch police station on December 12 under various sections of the BNS and provisions of the Drugs and Cosmetics Act.

“The seized material included around 1,200 tubes of spurious Betnovate-C ointment, over 2,700 tubes of fake Clop-G, more than 3,700 tubes of spurious Skin-Shine ointment, nearly 22,000 empty fake Clop-G tubes, over 350 kilograms of semi-prepared ointment, besides chemicals and manufacturing equipment,” the DCP said.

He said further investigation is underway to trace the entire supply chain, including wholesalers, distributors, delivery handlers and retailers involved in the illegal trade.

PTI

Published by
PTI
Tags: delhi

Recent Posts

Delhi airport: 100 international flights cancelled amid Middle East conflict

Around 100 international flights were cancelled at Delhi airport due to disruptions linked to the…

March 1, 2026

Gambler under heavy debt kills wife, 3 daughters in Delhi; nabbed from Rajasthan

Due to mounting debt and constant pressure, he decided to kill his family and leave…

March 1, 2026

Delhi: Mandoli jail inmate dies at GTB Hospital; probe initiated

According to the police, information was received from GTB Hospital regarding the admission of an…

March 1, 2026

Karan Aujla performs in Delhi, over 75,000 fans gather at venue

Over 75,000 fans filled Jawaharlal Nehru Stadium as Karan Aujla delivered one of India’s biggest…

March 1, 2026

2 minors among three held for involvement in robbery case in Delhi

Jewellery, silver and cash worth Rs 1.15 crore recovered after police apprehended three accused, including…

March 1, 2026

Tribes Art Fest 2026: Showcasing India’s tribal art and cultural heritage

Featuring over 70 tribal artists and 1,000 artworks, the festival at Travancore Palace will showcase…

March 1, 2026